即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1232416-25-9 | 货号 | BCP07948 |
中文名 | VE-822 | ||
英文名 | VE-822 | ||
中文别名 | |||
英文别名 | VE822; VE 822; VX970; VX-970; VX 970; Berzosertib; | ||
SMILES | |||
化学名称 | |||
分子式 | C24H25N5O3S | 分子量 | 463.55 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | VE-822, also known as VX-970 or Berzosertib, is an potent ATR inhibitor. VE-822 inhibited ATR in vitro and in vivo. VE-822 decreased maintenance of cell-cycle checkpoints, increased persistent DNA damage and decreased homologous recombination in irradiated cancer cells. VE-822 decreased survival of pancreatic cancer cells but not normal cells in response to XRT or gemcitabine. VE-822 markedly prolonged growth delay of pancreatic cancer xenografts after XRT and gemcitabine-based chemoradiation without augmenting normal cell or tissue toxicity. These findings support ATR inhibition as a promising new approach to improve the therapeutic ration of radiochemotherapy for patients with PDAC. |
Tags:VE-822 供应商,VE-822 购买,VE-822 生产,VE-822 批量,VE-822 供应,VE-822 订购,VE-822 采购